Increasing cancer drug prices present global challenges to treatment access and cancer
outcomes. Substantial variability exists in drug pricing across countries. In countries without …

Background: Out-of-pocket costs pose a substantial economic burden to cancer patients and
their families. The purpose of this study was to evaluate the literature on out-of-pocket costs …

BACKGROUND: Cancer projections to the current year help in policy development, planning
of programs and allocation of resources. We sought to provide an overview of the expected …

Background: Regular cancer surveillance is crucial for understanding where progress is
being made and where more must be done. We sought to provide an overview of the …

Nearly one in two Canadians are expected to be diagnosed with cancer in their lifetime.
However, there are opportunities to reduce the impact of modifiable cancer risk factors …

Goal To determine patient-reported financial and family burden associated with treatment of
cancer in the previous 28 days across Canada. Methods A self-administered questionnaire …

Cancer patients and their families experience considerable financial hardship; however, the
current published literature on the economic burden of cancer at the population level has …

Purpose Improving the understanding of co-existing chronic diseases prior to and after the
diagnosis of cancer may help to facilitate therapeutic decision making in clinical practice …

Background Cancer is the leading cause of death in Canada and the estimated annual
spending associated with cancer is approximately $7.5 billion. Projecting the future burden …

Importance Studies using data from before 2011 concluded that the cost of US cancer care
is justified given improved outcomes compared with European countries. However, it is …